大山 勝宏

Pharmacokinetic Models Scaled-up from Humanized-liver Mouse Data Can Account for Drug Monitoring Results of Atomoxetine and Its 4-Hydroxylated andN-Demethylated Metabolites in Pediatric Patients Genotyped for CytochromeP450 2D6 

Drug Metabolism and Disposition 52(1) 35-43 2024年1月  査読有り

Association of Torsade de Pointes and QT Prolongation With Antifungal Triazoles: Analysis Using a Pharmacovigilance Database. 

In vivo (Athens, Greece) 37(6) 2719-2725 2023年11月  査読有り筆頭著者責任著者

Plasma and Hepatic Exposures of Celecoxib and Diclofenac Prescribed Alone in Patients with Cytochrome P450 2C9*3 Modeled after Virtual Oral Administrations and Likely Associated with Adverse Drug Events Reported in a Japanese Database. 

Biological & pharmaceutical bulletin 46(6) 856-863 2023年6月1日  査読有り筆頭著者

High hepatic and plasma exposures of atorvastatin in subjects harboring impaired cytochrome P450 3A4∗16 modeled after virtual administrations and possibly associated with statin intolerance found in the Japanese adverse drug event report database. 

Drug metabolism and pharmacokinetics 49 100486-100486 2023年4月  査読有り筆頭著者

Inverse association between DPP-4 inhibitor use and fracture in older adults: A disproportionality analysis of the FAERS and JADER. 

International journal of clinical pharmacology and therapeutics 61(1) 16-23 2023年1月  査読有り筆頭著者責任著者

Pharmacovigilance study of the association between dipeptidyl peptidase-4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS). 

Scientific reports 12(1) 13122-13122 2022年7月30日  査読有り筆頭著者責任著者

Effect of Concomitant Drug Use on the Onset and Exacerbation of Diabetes Mellitus in Everolimus-Treated Cancer. 

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 25 245-252 2022年  査読有り筆頭著者責任著者

Association of gynecomastia with antidiabetic medications in older adults: Data mining from different national pharmacovigilance databases. 

International journal of clinical pharmacology and therapeutics 60(1) 24-31 2022年1月  査読有り筆頭著者責任著者

Time-to-onset of diabetes with everolimus use: analysis of a spontaneous reporting system database. 

Die Pharmazie 76(10) 515-518 2021年10月1日  査読有り筆頭著者責任著者

オンライン在宅医療実習の教育評価 

東京薬科大学研究紀要 (24) 45-49 2021年3月  

Association between anaphylaxis and anti-influenza drug use: An analysis of the Japanese Adverse Drug Event Report database. 

Drug discoveries & therapeutics 15(3) 150-155 2021年  査読有り

Analysis of the Time-To-Onset and Factors Affecting Clinical Outcomes of Immune Reconstitution Inflammatory Syndrome in People Living with HIV Using Data from the Japanese Spontaneous Reporting Database. 

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 24 153-160 2021年  査読有り

Psoriasis associated with ACE inhibitors: an analysis of the FAERS database. 

Die Pharmazie 75(10) 524-526 2020年10月1日  査読有り筆頭著者責任著者

模擬患者養成プログラムの組み立ての実際とシナリオの構造化 

東京薬科大学研究紀要 (23) 51-54 2020年3月  

Evaluation of syncope association with α1-adrenoceptor blockers in males using the FAERS database: impact of concomitant hypertension. 

Die Pharmazie 74(12) 755-759 2019年12月1日  査読有り筆頭著者責任著者

Onset time profiles for syncope associated with α1-adrenoceptor blockers in males: Analysis of a spontaneous adverse drug event database 

Pharmacology & pharmacy 9(12) 515-526 2018年12月  査読有り筆頭著者責任著者

Evaluation of the Association between Topical Prostaglandin F2α Analogs and Asthma Using the JADER Database: Comparison with β-Blockers. 

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 138(4) 559-564 2018年  査読有り筆頭著者責任著者

先発・後発輸液製剤の物理化学的性質に関する検討（第2報）―糖加電解質輸液（3号液）に関する検討― 

日本注射薬臨床情報学会誌 6 25-35 2017年6月  査読有り

Blood Pressure Elevation Associated with Topical Prostaglandin F2α Analogs: An Analysis of the Different Spontaneous Adverse Event Report Databases. 

Biological & pharmaceutical bulletin 40(5) 616-620 2017年5月  査読有り筆頭著者責任著者